Cervical cancer vaccine, also known as HPV vaccine, is a vaccine to prevent cervical cancer. Recently, GSK announced that the first cervical cancer vaccine was officially launched in the mainland of China, which means that many women can also get cervical cancer vaccine in the mainland, so how many injections are needed for cervical cancer vaccine? Where can I get vaccinated?
Where does cervical cancer vaccine hit home?
The first cervical cancer vaccine is officially launched in mainland China and is cheaper than Hong Kong's price.
GlaxoSmithKline (GSK) announced on July 31 that the first approved cervical cancer vaccine in mainland China, Hirsch? Has been officially launched. GSK said that the first batch of imported Hirsch has passed the inspection and release of relevant quality inspection departments in China and is now being supplied to the national market. Like other vaccines, the health institutions that provide Hirsch vaccination are community hospitals and community health service centers in various cities.
How much is cervical cancer vaccine?
Hirrishi was approved in China a year ago for vaccination of 9-25-year-old women, using a three dose vaccination program. According to GSK, the bidding price of the provinces that have won the bid is 580 yuan / piece, or 1740 yuan for three injections, but the final payment price of vaccinators in each province may be different.
The successful listing of the first cervical cancer vaccine in mainland China means that GSK has occupied a huge market ahead of its competitors.
Introduction of cervical cancer vaccine
Cervical cancer vaccine, also known as HPV vaccine, is a vaccine to prevent cervical cancer. Cervical cancer is mainly caused by the infection of human papillomavirus (HPV). The vaccine can effectively prevent the incidence of cervical cancer by preventing HPV infection, and can prevent the human body from infecting the human papillomavirus subtype variation covered by the vaccine. It is found that 99.7% of cervical cancer is caused by HPV infection. HPV can also cause other relatively rare cancers, such as penile cancer, laryngeal cancer, lung cancer and anal cancer. The main route of HPV transmission is sexual or skin to skin contact.
What are the types of vaccines?
99.7% of cervical cancer is caused by HPV infection. As long as women start to have sex, the risk of HPV infection is very high. This time, GlaxoSmithKline was allowed to enter the mainland of China's' Hirsch ', commonly known as the bivalent HPV vaccine, which can effectively prevent the infection of two genotypes of HPV-16 and HPV-18, and the cervical cancer and cervical precancerous lesions caused by these two genotypes accounted for almost 70% of all cases.
Bivalent vaccine: for HPV16 and 18 subtypes, these two subtypes are the main subtypes of cervical cancer, which can cover about 70% of cervical cancer.
Tetravalent vaccine: HPV6 and 11 are added to the bivalent vaccine, because 6 and 11 also cause 90% of condyloma acuminatum.
9-valent vaccine: Based on the 4-valent vaccine, it covers 31, 33, 45, 52, 58 (hpv52, 58 are the most easily infected in Asia), which can prevent 90% of cervical cancer.
How can bivalent vaccine be applied to 9-25-year-old people?
The applicable age of bivalent HPV vaccine approved by the State Food and drug administration is 9-25 years old, and it can't be used beyond 25 years old. However, in May this year, the tetravalent vaccine has been approved by the state. The applicable age of the tetravalent vaccine is 20-45 years old.